ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is New Ray Medicine International Holding Ltd. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-111.34%
EBIT to Interest (avg)
45.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.33
Tax Ratio
34.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.08%
ROE (avg)
22.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.10
EV to EBIT
-4.69
EV to EBITDA
-4.69
EV to Capital Employed
0.01
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.00%
ROE (Latest)
8.07%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(Q)
Highest at HKD 113.42 MM
OPERATING PROFIT MARGIN(Q)
Highest at -1.75 %
EPS(Q)
Highest at HKD -0.02
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 78.81% (YoY
Here's what is working for New Ray Medicine International Holding Ltd.
Net Sales
At HKD 113.42 MM has Grown at 153.73%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (HKD MM)
Net Sales
Highest at HKD 113.42 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Profit Margin
Highest at -1.75 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
EPS
Highest at HKD -0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Depreciation
At HKD 2.06 MM has Grown at 15.56%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for New Ray Medicine International Holding Ltd.
Raw Material Cost
Grown by 78.81% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
